Synonyms: | |
Status: | Approved (1996) |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
ATC: | A16AX03 |
UNII: | NT6K61736T |
InChI Key | VPZRWNZGLKXFOE-UHFFFAOYSA-M |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C10H11NaO2 |
Molecular Weight | 186.19 |
AlogP | 2.09 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 37.3 |
Molecular species | ACID |
Aromatic Rings | 1.0 |
Heavy Atoms | 12.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | - | - | 6340 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
- | - | - | 6340 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | 6340 | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IV
|
- | - | - | 6340 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Urea Cycle Disorders, Inborn | 4 | D056806 | ClinicalTrials |
Tuberculosis, Pulmonary | 2 | D014397 | ClinicalTrials |
Argininosuccinic Aciduria | 2 | D056807 | ClinicalTrials |
Huntington Disease | 2 | D006816 | ClinicalTrials |
Machado-Joseph Disease | 2 | D017827 | ClinicalTrials |
Leukemia | 2 | D007938 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
Muscular Atrophy, Spinal | 1 | D009134 | ClinicalTrials |
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | D015325 | ClinicalTrials |
Amyotrophic Lateral Sclerosis | 1 | D000690 | ClinicalTrials |
Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Myelodysplastic-Myeloproliferative Diseases | 1 | D054437 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 75316 |
ChEMBL | CHEMBL1746 |
EPA CompTox | DTXSID7040948 |
FDA SRS | NT6K61736T |
PharmGKB | PA166114316 |
SureChEMBL | SCHEMBL125792 |